|
WO1998012274A1
(fr)
|
1996-09-23 |
1998-03-26 |
Chandrashekar Pathak |
Procedes et dispositifs pour preparer des concentres de proteines
|
|
US8003705B2
(en)
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
|
US6258351B1
(en)
*
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
|
US6371975B2
(en)
|
1998-11-06 |
2002-04-16 |
Neomend, Inc. |
Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
|
|
US20030191496A1
(en)
|
1997-03-12 |
2003-10-09 |
Neomend, Inc. |
Vascular sealing device with microwave antenna
|
|
US7642323B2
(en)
|
1997-11-06 |
2010-01-05 |
Nektar Therapeutics |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
|
US6448369B1
(en)
|
1997-11-06 |
2002-09-10 |
Shearwater Corporation |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
|
US6514534B1
(en)
|
1998-08-14 |
2003-02-04 |
Incept Llc |
Methods for forming regional tissue adherent barriers and drug delivery systems
|
|
US6994686B2
(en)
|
1998-08-26 |
2006-02-07 |
Neomend, Inc. |
Systems for applying cross-linked mechanical barriers
|
|
US6458147B1
(en)
|
1998-11-06 |
2002-10-01 |
Neomend, Inc. |
Compositions, systems, and methods for arresting or controlling bleeding or fluid leakage in body tissue
|
|
US6830756B2
(en)
|
1998-11-06 |
2004-12-14 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US7279001B2
(en)
|
1998-11-06 |
2007-10-09 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US6949114B2
(en)
|
1998-11-06 |
2005-09-27 |
Neomend, Inc. |
Systems, methods, and compositions for achieving closure of vascular puncture sites
|
|
US6899889B1
(en)
|
1998-11-06 |
2005-05-31 |
Neomend, Inc. |
Biocompatible material composition adaptable to diverse therapeutic indications
|
|
US8802146B2
(en)
*
|
1998-11-06 |
2014-08-12 |
Neomend, Inc. |
Systems, methods, and compositions for prevention of tissue adhesion
|
|
EP1137373A4
(fr)
*
|
1998-12-04 |
2004-05-19 |
Chandrashekhar P Pathak |
Polymeres reticules biocompatibles
|
|
EP2311895B1
(fr)
|
1999-02-01 |
2017-04-12 |
Eidgenössische Technische Hochschule Zürich |
Biomatériaux formés par réaction d'addition nucléophile à des groupes non saturés conjugués
|
|
US6958212B1
(en)
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
US7008635B1
(en)
|
1999-09-10 |
2006-03-07 |
Genzyme Corporation |
Hydrogels for orthopedic repair
|
|
MXPA02003540A
(es)
*
|
1999-10-08 |
2003-09-12 |
Nektar Therapeutics Al Corp |
Derivados de poli(etilenglicol) heterobifuncionales y los metodos para su preparacion.
|
|
US6413507B1
(en)
*
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
EP1246608A4
(fr)
*
|
2000-01-05 |
2005-05-18 |
Imarx Therapeutics Inc |
Formulations pharmaceutiques pour l'administration de medicaments ayant une faible solubilite aqueuse
|
|
US7291673B2
(en)
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
|
CA2426692C
(fr)
|
2000-10-19 |
2011-01-25 |
Eidgenossische Technische Hochschule Zurich |
Copolymeres blocs pour systemes auto-assembles multifonctionnels
|
|
US7829074B2
(en)
|
2001-10-18 |
2010-11-09 |
Nektar Therapeutics |
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
|
|
EP1421216A4
(fr)
*
|
2001-09-01 |
2006-05-17 |
Samsung Electronics Co Ltd |
Procede pour fabriquer une biopuce en hydrogel au moyen d'un derive de polyethyleneglycol etoile comportant un groupe epoxy
|
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
|
EP2292273A3
(fr)
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodelage et Glycoconjugaison de Peptides
|
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
WO2003051113A1
(fr)
|
2001-12-14 |
2003-06-26 |
The University Of Wyoming |
Methodes et compositions de liberation controlee de medicaments
|
|
US7569214B2
(en)
|
2002-09-09 |
2009-08-04 |
Nektar Therapeutics Al, Corporation |
Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
|
|
US7045552B2
(en)
*
|
2002-09-27 |
2006-05-16 |
Trimeris, Inc. |
Pharmaceutical composition for improved administration of HIV gp41-derived peptides, and its use in therapy
|
|
AU2004221824B2
(en)
|
2003-03-14 |
2009-08-27 |
Ratiopharm Gmbh |
Branched water-soluble polymers and their conjugates
|
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
|
CA2522345A1
(fr)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes
|
|
US7932364B2
(en)
|
2003-05-09 |
2011-04-26 |
Novo Nordisk A/S |
Compositions and methods for the preparation of human growth hormone glycosylation mutants
|
|
US6787443B1
(en)
*
|
2003-05-20 |
2004-09-07 |
Intel Corporation |
PCB design and method for providing vented blind vias
|
|
WO2005012484A2
(fr)
|
2003-07-25 |
2005-02-10 |
Neose Technologies, Inc. |
Conjugues anticorps-toxines
|
|
EP1680443B9
(fr)
|
2003-11-05 |
2014-09-03 |
Dana-Farber Cancer Institute, Inc. |
Peptides stabilises structures en helice alpha et leurs utilisations
|
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
|
US7956032B2
(en)
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
|
RU2006128593A
(ru)
*
|
2004-01-07 |
2008-02-20 |
Тримерис, Инк. (Us) |
Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека
|
|
NZ548123A
(en)
|
2004-01-08 |
2010-05-28 |
Novo Nordisk As |
O-linked glycosylation of peptides
|
|
DE602004011660T2
(de)
|
2004-06-16 |
2009-01-29 |
Straumann Holding Ag |
Abdeckmembran
|
|
US7282584B2
(en)
|
2004-06-16 |
2007-10-16 |
Straumann Holding Ag |
Methylene blue
|
|
WO2006010143A2
(fr)
|
2004-07-13 |
2006-01-26 |
Neose Technologies, Inc. |
Remodelage de peg ramifie et glycosylation de peptide-1 semblable a glucagon [glp-1]
|
|
WO2006031811A2
(fr)
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Interferon alpha glycopegyle
|
|
EP1814573B1
(fr)
|
2004-10-29 |
2016-03-09 |
ratiopharm GmbH |
Remodelage et glycopegylation du facteur de croissance des fibroblastes (fgf)
|
|
CA2593682C
(fr)
|
2005-01-10 |
2016-03-22 |
Neose Technologies, Inc. |
Facteur de stimulation de colonie de granulocytes glycopegylatees
|
|
AU2006213822B2
(en)
|
2005-02-09 |
2011-05-26 |
Covidien Lp |
Synthetic sealants
|
|
US7517914B2
(en)
|
2005-04-04 |
2009-04-14 |
Boston Scientificscimed, Inc. |
Controlled degradation materials for therapeutic agent delivery
|
|
US9187546B2
(en)
|
2005-04-08 |
2015-11-17 |
Novo Nordisk A/S |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
|
US20080255026A1
(en)
|
2005-05-25 |
2008-10-16 |
Glycopegylated Factor 1X |
Glycopegylated Factor Ix
|
|
WO2006127910A2
(fr)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Formulations d'erythropoietine glycopegylees
|
|
WO2007008300A2
(fr)
|
2005-05-31 |
2007-01-18 |
ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE |
Copolymeres triblocs pour l'administration cytoplasmique de medicaments a base de genes
|
|
US8367096B2
(en)
|
2005-07-19 |
2013-02-05 |
Boston Scientific Scimed, Inc. |
Polymers having covalently bound therapeutic agents
|
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
|
US20090048440A1
(en)
|
2005-11-03 |
2009-02-19 |
Neose Technologies, Inc. |
Nucleotide Sugar Purification Using Membranes
|
|
CA2630327C
(fr)
|
2005-12-08 |
2015-05-26 |
Tyco Healthcare Group Lp |
Compositions chirurgicales biocompatibles
|
|
ATE537183T1
(de)
|
2006-02-02 |
2011-12-15 |
Trimeris Inc |
Hiv-fusionshemmerpeptide mit verbesserten biologischen eigenschaften
|
|
US7597882B2
(en)
|
2006-04-24 |
2009-10-06 |
Incept Llc |
Protein crosslinkers, crosslinking methods and applications thereof
|
|
US7960498B2
(en)
*
|
2006-06-30 |
2011-06-14 |
Actamax Surgical Materials, Llc |
Tissue adhesives with modified elasticity
|
|
CN101516388B
(zh)
|
2006-07-21 |
2012-10-31 |
诺和诺德公司 |
通过o-联糖基化序列的肽的糖基化
|
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
|
WO2008060780A2
(fr)
|
2006-10-04 |
2008-05-22 |
Novo Nordisk A/S |
Glycopeptides et sucres pégylés à liaison glycérol
|
|
US8889632B2
(en)
|
2007-01-31 |
2014-11-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
|
US20090227981A1
(en)
*
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
|
US20090227689A1
(en)
*
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
|
JP5052919B2
(ja)
*
|
2007-03-08 |
2012-10-17 |
成均▲館▼大學校 産學協力團 |
Ph及び温度敏感性のブロック共重合体ヒドロゲル
|
|
EP2508531B1
(fr)
|
2007-03-28 |
2016-10-19 |
President and Fellows of Harvard College |
Polypeptides piqués
|
|
EP2144923B1
(fr)
|
2007-04-03 |
2013-02-13 |
BioGeneriX AG |
Méthodes de traitement à l'aide d'un facteur g-csf glycopégylé
|
|
CN101678125A
(zh)
*
|
2007-04-03 |
2010-03-24 |
特里梅里斯公司 |
用于递送抗病毒肽治疗剂的新制剂
|
|
WO2008154639A2
(fr)
|
2007-06-12 |
2008-12-18 |
Neose Technologies, Inc. |
Procédé amélioré pour la production de sucres de nucléotide
|
|
US9125807B2
(en)
*
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
|
US8067028B2
(en)
*
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
|
CA2700354A1
(fr)
*
|
2007-09-25 |
2009-04-02 |
Trimeris, Inc. |
Nouveaux procedes de synthese pour des peptides antiviraux therapeutiques
|
|
WO2009060354A1
(fr)
*
|
2007-11-08 |
2009-05-14 |
Koninklijke Philips Electronics N.V. |
Procédé et dispositif électronique de gestion de contenu
|
|
EP2247645B1
(fr)
*
|
2008-02-13 |
2017-12-06 |
Hyperbranch Medical Technology, Inc. |
Hydrogels à base de polyalkylèneimines réticulées à taux de dégradation ajustable
|
|
JP5150297B2
(ja)
*
|
2008-02-14 |
2013-02-20 |
ネクター セラピューティックス エイエル,コーポレイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
|
US20130189239A1
(en)
|
2008-02-27 |
2013-07-25 |
Novo Nordisk A/S |
Conjugated Factor VIII Molecules
|
|
CN102203126A
(zh)
|
2008-09-22 |
2011-09-28 |
爱勒让治疗公司 |
用于制备纯化的多肽组合物的方法
|
|
US9271929B2
(en)
|
2008-11-25 |
2016-03-01 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Block copolymers and uses thereof
|
|
EP2376100B1
(fr)
|
2009-01-14 |
2017-10-25 |
Aileron Therapeutics, Inc. |
Macrocycles peptidomimetiques
|
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
|
DK3266463T3
(da)
|
2009-06-09 |
2024-01-08 |
Prolong Pharmaceuticals Llc |
Hæmoglobinsammensætninger
|
|
DK2459171T3
(en)
|
2009-07-31 |
2017-09-25 |
Sanofi Aventis Deutschland |
Long-acting insulin composition
|
|
LT2459220T
(lt)
*
|
2009-07-31 |
2020-12-28 |
Ascendis Pharma A/S |
Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
|
|
KR20120089843A
(ko)
|
2009-07-31 |
2012-08-14 |
사노피-아벤티스 도이칠란트 게엠베하 |
인슐린 링커 접합체를 포함한 프로드럭
|
|
CA2774973A1
(fr)
|
2009-09-22 |
2011-03-31 |
Aileron Therapeutics, Inc. |
Macrocycles peptidomimetiques
|
|
AU2010311421B2
(en)
|
2009-10-29 |
2014-11-20 |
Ascendis Pharma A/S |
Sterilization of biodegradable hydrogels
|
|
EP3960215B1
(fr)
|
2009-12-15 |
2024-10-16 |
Incept, LLC |
Implants et marqueurs de repère biodégradables
|
|
US8524215B2
(en)
*
|
2010-08-02 |
2013-09-03 |
Janssen Biotech, Inc. |
Absorbable PEG-based hydrogels
|
|
SI2603600T1
(sl)
|
2010-08-13 |
2019-04-30 |
Aileron Therapeutics, Inc. |
Peptidomimetični makrocikli
|
|
EP2438930A1
(fr)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Promédicaments comprenant un conjugué de liaison d'exendine
|
|
EP2637680B1
(fr)
|
2010-11-12 |
2017-03-01 |
Dana-Farber Cancer Institute, Inc. |
Thérapies du cancer
|
|
US8440309B2
(en)
|
2011-01-31 |
2013-05-14 |
Confluent Surgical, Inc. |
Crosslinked polymers with the crosslinker as therapeutic for sustained release
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
TW201806968A
(zh)
|
2011-10-18 |
2018-03-01 |
艾利倫治療公司 |
擬肽巨環化合物
|
|
AU2012332495B2
(en)
|
2011-11-03 |
2017-06-08 |
The Trustees Of Columbia University In The City Of New York |
Composition with sustained antimicrobial activity
|
|
US9205150B2
(en)
|
2011-12-05 |
2015-12-08 |
Incept, Llc |
Medical organogel processes and compositions
|
|
WO2013102211A2
(fr)
|
2011-12-29 |
2013-07-04 |
Walensky Loren D |
Hélices hybrides stabilisées antivirales
|
|
KR102112373B1
(ko)
|
2012-02-15 |
2020-05-18 |
에일러론 테라퓨틱스 인코포레이티드 |
펩티드모방체 마크로사이클
|
|
HK1205454A1
(en)
|
2012-02-15 |
2015-12-18 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
|
JP5953459B2
(ja)
*
|
2012-03-27 |
2016-07-20 |
ネクター セラピューティクス |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
|
US9395468B2
(en)
|
2012-08-27 |
2016-07-19 |
Ocular Dynamics, Llc |
Contact lens with a hydrophilic layer
|
|
US10201613B2
(en)
*
|
2012-09-07 |
2019-02-12 |
The Regents Of The University Of California |
Method of creating hydrogels through oxime bond formation
|
|
CA3113959A1
(fr)
|
2012-09-26 |
2014-04-03 |
President And Fellows Of Harvard College |
Peptides agrafes bloques par la proline et leurs utilisations
|
|
KR101450859B1
(ko)
*
|
2012-10-10 |
2014-10-15 |
한국과학기술연구원 |
염증 억제용 약물을 구비한 신경 전극 및 그 제조 방법
|
|
JP6271566B2
(ja)
|
2012-10-11 |
2018-01-31 |
アセンディス ファーマ エー/エス |
ヒドロゲルプロドラッグ
|
|
WO2014071241A1
(fr)
|
2012-11-01 |
2014-05-08 |
Aileron Therapeutics, Inc. |
Acides aminés disubstitués et procédés de préparation et d'utilisation de ceux-ci
|
|
EP3782638A1
(fr)
|
2013-03-13 |
2021-02-24 |
President and Fellows of Harvard College |
Polypeptides piqués et agrafés et leurs utilisations
|
|
CA2906775A1
(fr)
|
2013-03-15 |
2014-09-18 |
Dana-Farber Cancer Institute, Inc. |
Peptides bh4 stabilises et leurs utilisations
|
|
WO2014144148A1
(fr)
|
2013-03-15 |
2014-09-18 |
Dana-Farber Cancer Institute, Inc. |
Peptides sos1 stabilisés
|
|
WO2014151369A2
(fr)
|
2013-03-15 |
2014-09-25 |
Dana-Farber Cancer Institute, Inc. |
Peptide d'ezh2 stabilisé
|
|
WO2014201370A1
(fr)
|
2013-06-14 |
2014-12-18 |
President And Fellows Of Harvard College |
Modulateurs stabilisés du récepteur de l'insuline polypeptidique
|
|
WO2015013510A1
(fr)
|
2013-07-25 |
2015-01-29 |
Ecole Polytechnique Federale De Lausanne Epfl |
Matériaux en nanofibrilles à rapport d'aspect élevé
|
|
EP3570093B1
(fr)
|
2013-11-15 |
2021-09-15 |
Tangible Science, Inc. |
Lentille de contact dotée d'une couche hydrophile
|
|
CN114805527A
(zh)
|
2014-05-21 |
2022-07-29 |
哈佛大学的校长及成员们 |
Ras抑制肽和其用途
|
|
IL282559B
(en)
|
2014-07-17 |
2022-07-01 |
Univ California |
Controllable self-annealing microgel particles for biomedical applications
|
|
BR112017005598A2
(pt)
|
2014-09-24 |
2017-12-12 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos e usos dos mesmos
|
|
JP2018503595A
(ja)
|
2014-09-24 |
2018-02-08 |
エルロン・セラピューティクス・インコーポレイテッドAileron Therapeutics,Inc. |
ペプチド模倣大環状分子およびその製剤
|
|
CN107206119B
(zh)
|
2014-12-09 |
2021-01-29 |
实体科学公司 |
具有生物相容性层的医疗设备涂层
|
|
EP3270945A4
(fr)
|
2015-03-18 |
2018-09-05 |
Massachusetts Institute of Technology |
Peptides de liaison à mcl-1 sélectifs
|
|
WO2016154058A1
(fr)
|
2015-03-20 |
2016-09-29 |
Aileron Therapeutics, Inc. |
Macrocycles peptidomimétiques et leurs utilisations
|
|
WO2016183296A1
(fr)
|
2015-05-12 |
2016-11-17 |
Incept, Llc |
Administration de médicament à partir d'hydrogels
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US10464975B2
(en)
|
2015-07-02 |
2019-11-05 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides
|
|
JP7049989B2
(ja)
|
2015-08-28 |
2022-04-07 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Bfl-1と結合するペプチド
|
|
US20190002506A1
(en)
|
2015-08-28 |
2019-01-03 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptides for covalent binding to target protein
|
|
US10023613B2
(en)
|
2015-09-10 |
2018-07-17 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of MCL-1
|
|
JP6184462B2
(ja)
*
|
2015-10-28 |
2017-08-23 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
|
WO2017142879A1
(fr)
|
2016-02-16 |
2017-08-24 |
The Regents Of The University Of California |
Procédé de modulation du système immunitaire avec des gels de particules hybridées microporeuses
|
|
CN109069578A
(zh)
|
2016-02-29 |
2018-12-21 |
达纳-法伯癌症研究所股份有限公司 |
用于治疗感染的钉合的细胞内靶向抗微生物肽
|
|
JP6925579B2
(ja)
*
|
2016-03-31 |
2021-08-25 |
日油株式会社 |
環状ベンジリデンアセタール構造を有する生分解性ヒドロゲル
|
|
US20190133126A1
(en)
*
|
2016-05-16 |
2019-05-09 |
The Trustees Of Columbia University In The City Of New York |
Coatings and methods for infection-resistant medical devices
|
|
US11198715B2
(en)
|
2016-07-22 |
2021-12-14 |
Massachusetts Institute Of Technology |
Selective Bfl-1 peptides
|
|
ES2935622T3
(es)
|
2016-08-26 |
2023-03-08 |
Dana Farber Cancer Inst Inc |
Polipéptidos y miméticos de bcl-w para el tratamiento o la prevención de la neuropatía periférica y la pérdida auditiva inducidas por la quimioterapia
|
|
US11613607B2
(en)
|
2016-10-07 |
2023-03-28 |
Tokyo Institute Of Technology |
Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof
|
|
US12344643B2
(en)
|
2016-12-07 |
2025-07-01 |
The University Of Chicago |
Compositions and methods for inhibition of FOXP3
|
|
WO2018136205A1
(fr)
|
2016-12-29 |
2018-07-26 |
Tempo Therapeutics, Inc. |
Procédés et systèmes de traitement d'un site d'implant médical
|
|
WO2018170299A1
(fr)
|
2017-03-15 |
2018-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibiteurs de transcription de gène procaryote et leurs utilisations
|
|
JP6361083B2
(ja)
*
|
2017-06-27 |
2018-07-25 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
|
AU2018304230A1
(en)
|
2017-07-19 |
2020-02-06 |
Dana-Farber Cancer Institute, Inc. |
Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
|
|
CN120118207A
(zh)
|
2017-12-15 |
2025-06-10 |
丹娜-法伯癌症研究院有限公司 |
稳定肽-介导的靶向蛋白降解
|
|
WO2019118719A1
(fr)
|
2017-12-15 |
2019-06-20 |
Dana-Farber Cancer Institute, Inc. |
Ciblage sélectif des protéines d'apoptose par des peptides noxa structuralement stabilisés et/ou réactifs à la cystéine
|
|
EP3749678A1
(fr)
|
2018-02-07 |
2020-12-16 |
Dana Farber Cancer Institute, Inc. |
Modules peptidiques agrafés perméables aux cellules pour administration cellulaire
|
|
EP3765852A1
(fr)
|
2018-03-14 |
2021-01-20 |
Dana Farber Cancer Institute, Inc. |
Peptides stabilisés de détection de biomarqueurs
|
|
JP6500318B2
(ja)
*
|
2018-04-04 |
2019-04-17 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
ヘテロ二官能性ポリエチレングリコール誘導体およびその調製方法
|
|
CN109939065B
(zh)
*
|
2018-08-10 |
2021-08-03 |
上海瑞凝生物科技有限公司 |
医用水凝胶
|
|
WO2020060975A1
(fr)
|
2018-09-17 |
2020-03-26 |
Massachusetts Institute Of Technology |
Peptides sélectifs pour des protéines de la famille bcl-2
|
|
US12194264B2
(en)
*
|
2018-11-02 |
2025-01-14 |
Bionaut Labs Ltd. |
Magnetomechanic triggering of payload release from miniaturized devices
|
|
JP7727551B2
(ja)
|
2019-04-18 |
2025-08-21 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
構造的に安定化されたペプチドによるユビキチンおよびユビキチン様e1活性化酵素の選択的標的化
|
|
AU2020340441A1
(en)
*
|
2019-08-29 |
2022-03-24 |
Paul Douglas Godfrin |
Hydrogels as oral delivery dosage forms, methods of making and using same
|
|
JP2022552829A
(ja)
*
|
2019-10-08 |
2022-12-20 |
インキューブ ラブズ, エルエルシー |
徐放性製剤送達デバイス
|
|
WO2021126827A1
(fr)
|
2019-12-16 |
2021-06-24 |
Dana-Farber Cancer Institute, Inc. |
Peptides oncolytiques structurellement stabilisés et leurs utilisations
|
|
WO2021127493A1
(fr)
|
2019-12-20 |
2021-06-24 |
Dana-Farber Cancer Institute, Inc. |
Peptides type peptide 1 apparenté au glucagon structuralement stabilisés et leurs utilisations
|
|
JP7894318B2
(ja)
|
2020-03-04 |
2026-07-23 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
抗ウイルスの構造的に安定化されたSARS-CoV-2ペプチドおよびその使用
|
|
WO2021216845A1
(fr)
|
2020-04-22 |
2021-10-28 |
Dana-Farber Cancer Institute, Inc. |
Peptides de type hélice 1 d'ace2 antiviraux structuralement stabilisés et leurs utilisations
|
|
AU2021262752A1
(en)
|
2020-04-27 |
2022-10-13 |
Dana-Farber Cancer Institute, Inc. |
Structurally-stabilized and HDMX-selective p53 peptides and uses thereof
|
|
CN115803034A
(zh)
|
2020-07-16 |
2023-03-14 |
3M创新有限公司 |
用于毒力抑制的含磷酸酯的共聚物
|
|
WO2022081827A1
(fr)
|
2020-10-14 |
2022-04-21 |
Dana-Farber Cancer Institute, Inc. |
Conjugués chimériques destinés à la dégradation de protéines virales et de protéines hôtes et méthodes d'utilisation
|
|
WO2022098848A1
(fr)
|
2020-11-05 |
2022-05-12 |
Dana-Farber Cancer Institute, Inc. |
Peptides antiviraux structurellement stabilisés pour lutter contre le virus ebola et leurs utilisations
|
|
US12552834B2
(en)
|
2021-01-25 |
2026-02-17 |
Massachusetts Institute Of Technology |
Selective MENA binding peptides
|
|
CN114907580B
(zh)
*
|
2021-02-09 |
2024-11-29 |
上海瓴就医疗科技有限公司 |
一种可降解的双组份水凝胶及其制备方法与应用
|
|
MX2024002824A
(es)
|
2021-09-08 |
2024-06-28 |
Dana Farber Cancer Inst Inc |
Conjugados antivirales de peptido de coronavirus 2 del sindrome respiratorio agudo severo (sars-cov-2)-colesterol estructuralmente engrapados y usos de los mismos.
|
|
EP4518900A1
(fr)
|
2022-05-04 |
2025-03-12 |
Dana-Farber Cancer Institute, Inc. |
Peptides de glycoprotéines de surface d'ebolavirus, conjugués et utilisations de ceux-ci
|
|
CN114767920B
(zh)
*
|
2022-05-13 |
2023-08-29 |
中国科学院长春应用化学研究所 |
一种聚乙二醇基粘合剂及其制备方法以及应用
|